https://pembrolizumabinhibitor.....com/quantitative-he
, PubMed and Scopus). Afterward, the relevant data were extracted from the selected studies, then analyzed by the STATA (Version 14) random-effects design. The 30 studies selected for our meta-analysis covered 6,389 infected patients. The prevalence prices of the most typical signs had been as follows fever 84.30% (95% CI 77.13-90.37; I2 = 97.74%), cough 63.01% (95% CI 57.63-68.23; I2 = 93.73%), dyspnea 37.16% (95% CI 27.31-47.57%; I2 = 98.32%), exhaustion 34.22% (95% CI 26.29-42.62; I
Like
Comment
Share
